Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maine for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maine only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maine (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Devon Evans (NPI 1518183532)

Field	Value
Entity Type	Individual
Organization	Devon Evans
Address	11 Rock Row Ste 120
City	Westbrook
State	ME
ZIP	04092
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	April 18, 2007

Payer Source	Total Paid
Medicare	$1.5M
Medicaid	$0

Key Findings

This provider reports $1.5M in total Medicare revenue and none (no Medicaid billing on file), making their Medicare business the effective sole public payer exposure. The dataset notes that the top 3 Medicare codes by revenue account for 75.6% of this provider's total Medicare revenue, indicating heavy concentration in a small set of high-cost services.

Revenue is overwhelmingly driven by J9271: Injection, pembrolizumab, 1 mg, which accounts for $774K in revenue or 54.2% of Medicare receipts and is reported on 18K claims at $43 avg paid/claim. Nationally this provider ranks #502 of 1841 for J9271 (72nd percentile) — a mid-to-upper national position that the source characterizes as typical/unremarkable volume rather than dominant market share.

The second-largest Medicare revenue driver is J0897: Injection, denosumab, 1 mg, contributing $205.2K or 14.4% of Medicare revenue (11.4K claims at $18 avg paid/claim). The provider ranks #910 of 10057 nationally for J0897 (91st percentile); this is a relatively high national rank for that code, though the dataset labels the volume as typical/unremarkable in the broader provider population.

J1569: Injection, immune globulin (gammagard liquid), 500 mg, is the third top code at $100.4K or 7.0% of Medicare revenue (2.8K claims at $36 avg paid/claim). The provider ranks #328 of 542 nationally for J1569 (39th percentile), indicating a more modest position among the smaller cohort of clinicians who bill this product.

Code mix and procedures indicate an infusion-centered hematology/oncology practice: presence of chemotherapy administration codes such as 96413, add-on codes like 96417 and 96411, ambulatory infusion codes 96365/96375, and the chemotherapy initiation/continuation code G0498 point to in-office systemic therapy delivery. Supporting services billed include labs and blood draws (80053, 85025, 36415), consistent with same-day infusion monitoring and oncology follow-up workflows.

Evaluation-and-management activity is meaningful: 99214 accounts for $93.2K (6.5% of Medicare revenue) across 981 claims at $95 avg paid/claim and the provider ranks #11961 of 479517 for 99214 (97th percentile), a position the data flags as notably above typical national volume. This suggests substantial ongoing outpatient management and follow-up of established oncology patients in addition to drug administration.

There are specific procedural usage outliers for supportive-care infusion flows: 96360 (IV catheter insertion for supplementation, 31 minutes–1 hour) appears at 208 claims, $5.4K revenue (0.4% of Medicare revenue) and ranks #72 of 2672 (97th percentile), which the source labels as notably above typical national volume. High relative use of 96360 alongside the high-volume infusion drugs implies frequent IV access procedures and throughput consistent with a busy infusion suite.

The provider has a long Medicare enrollment history, with NPI enumerated 2007-04-18 (~19 years ago), indicating sustained participation in Medicare and operational continuity that supports repeated high-volume biologic and chemotherapy administration over time.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

62 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	18,000	$40	$774K
J0897	Injection, denosumab, 1 mg	11,400	$20	$205.2K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	2,790	$40	$100.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	980	$100	$93.2K
J1439	Injection, ferric carboxymaltose, 1 mg	45,750	$1	$45.8K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	440	$100	$45K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	240	$140	$31.7K
J1454	Injection, fosnetupitant 235 mg and palonosetron 0.25 mg	70	$360	$25.1K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	120	$130	$16.1K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	240	$50	$12.2K

Showing 1–10 of 62

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 62 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maine Distribution

Devon Evans — 8 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maine

Full comparison — all codes billed, vs. state median

62 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	4	10	16,450	$40	$699.2K
J1569	5	10	3,150	$40	$144.9K
J0897	2	20	2,730	$20	$86.4K
J1439	3	10	24,750	$1	$32.2K
J9217	3	10	120	$130	$27.9K
96413	2	30	170	$100	$20.6K
J1454	2	10	60	$340	$18.3K
G0498	1	10	60	$210	$11.6K
99214	5	2,500	70	$70	$7.2K
96365	4	30	90	$50	$5.6K

Showing 1–10 of 62

Related Providers

Other providers that share a Tax Identification Number (TIN) with Devon Evans, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mercy Hospital	ME	General Acute Care Hospital	$0	$35.5M
Can Ilyas	ME	Hematology & Oncology Physician	$3.2M	$0
David Benton	ME	Hematology & Oncology Physician	$2.6M	$0
Matthew Dugan	ME	Hematology & Oncology Physician	$1.8M	$0
John Winters	ME	Hematology & Oncology Physician	$1.5M	$0
Maine Center For Cancer Medicine & Blood Disorders, P.A.	ME	Hematology & Oncology Physician	$0	$1.5M
Christian Thomas	ME	Hematology & Oncology Physician	$1.5M	$0
Brian Haney	ME	Hematology & Oncology Physician	$1.2M	$0
Yoko Fukuda	NH	Hematology & Oncology Physician	$945K	$0
Philip Russell	ME	Psychiatry Physician	$14.5K	$720.3K

Nearby Providers

Other providers in the same ZIP code as Devon Evans, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Creative Works	ME	Developmentally Disabled Services Day Training Agency	$0	$144.1M
Woodfords Family Services	ME	Community/Behavioral Health Agency	$0	$101.5M
Safe Residential Care, LLC	ME	Physical Disabilities Residential Treatment Facility	$0	$94.6M
3rivers, Inc.	ME	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$78.6M
Woodfords Family Services	ME	Community/Behavioral Health Agency	$0	$46.3M
Alliance Case Management	ME	Case Management Agency	$0	$17.8M
Woodfords Family Services	ME	In Home Supportive Care Agency	$0	$11.3M
Woodfords Family Services	ME	Case Management Agency	$0	$9.4M
Mas Medical Staffing Corporation	ME	Home Health Agency	$0	$8.1M
Maine Community Homecare	ME	In Home Supportive Care Agency	$0	$8.1M

Devon Evans — Billing Profile & Reimbursement Data

Sign up for Devon Evans — Billing Profile & Reimbursement Data policy alerts

Devon Evans — Billing Profile & Reimbursement Data

Sign up for Devon Evans — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References